Edward B Jude
Edward B Jude is an expert in Endocrinology at Tameside and Glossop Integrated Care NHS Foundation Trust (United Kingdom). As of October 2026, ScienceLeadR ranks Edward B Jude in the top 1% of experts worldwide for Foot Diseases, Diabetic Neuropathies and Skin Ulcer. Edward B Jude has authored 277 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 1,089 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Nutrition - Cardiology - Rheumatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 277
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Cybersecurity of Smart Sensing Insole Systems: A Threat Modelling Approach to Understanding Security Vulnerabilities. PMID 42884498 — diabetes mellitus, trust, disclosure, foot, foot ulcer, amputation, surgical, ulcer, diabetic foot, computer security | Sensors (Basel) | 2026 | 0 |
| Screening for Depression and Anxiety in People With Diabetes and a Foot Ulcer in the Podiatry Clinic. PMID 42755053 — diabetes mellitus, depression, polypharmacy, foot, foot ulcer, ulcer, signs and symptoms, podiatry | J Foot Ankle Res | 2026 | 0 |
| Arginine vasopressin deficiency following SARS-CoV-2 infection: a rare pituitary complication. PMID 42546065 — arginine vasopressin, diabetes insipidus, neurogenic, sars-cov-2, arginine, covid-19, severe acute respiratory syndrome-related coronavirus, infections | Endocrinol Diabetes Metab Case Rep | 2026 | 0 |
| Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial. PMID 42035781 — diabetes mellitus, self-management, blood glucose, insulin, blood, therapeutics, diabetes mellitus, type 2, continuous glucose monitoring | Lancet Diabetes Endocrinol Top journal | 2026 | 0 |
| Development and Multicenter External Validation of a Real-Time Artificial Intelligence Diagnostic System for Diabetic Peripheral Neuropathy Based on Wearable Devices. PMID 41950120 — intelligence, peripheral nervous system diseases, classification, wearable electronic devices, artificial intelligence, geriatrics, forests | Gerontology | 2026 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Convenient Home Access for Routine Monitoring in Diabetes (Charm D Study) NCT06695325 — diabetes mellitus, skin, blood glucose, laboratories, blood, capillaries, sugars, thyroid gland, therapeutics, economics, lipids | N/A | Recruiting | 2025 |
| CGM Use in Adults With Type 2 Diabetes on Basal Insulin NCT05944432 — diabetes mellitus, glucagon-like peptide 1, sodium-glucose transporter 2 inhibitors, blood glucose, insulin, blood, therapeutics, blood glucose self-monitoring, diabetes mellitus, type 2, continuous glucose monitoring | N/A | Active not recruiting | 2023 |
LeadR Networks
Main global connection map